| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/29/2002 | US20020119160 Human T cell response to MHC-binding motif clusters |
| 08/29/2002 | US20020119158 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/29/2002 | US20020119157 For cancer therapy |
| 08/29/2002 | US20020119156 Polynucleotides and polypeptides which are diagnostic markers for lung cance |
| 08/29/2002 | US20020119155 Protein-protein interactions in neurodegenerative diseases |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119150 Administering an effective amount of a CD40:CD154 binding interrupter to primate graft recipient for therapy of rejection of tissue graft |
| 08/29/2002 | US20020119149 Multivalent T cell receptor complexes |
| 08/29/2002 | US20020119148 ErbB4 antagonists |
| 08/29/2002 | US20020119137 Useful in treating metabolic disorders or disorders associated with changes in adipose tissue physiological function or mass |
| 08/29/2002 | US20020119135 For therapy of neurodegenerative diseases characterized by apoptosis, including Parkinson's disease and Alzheimer's disease; blood clots, which left untreated could result in stroke; autoimmune diseasesl; cancer |
| 08/29/2002 | US20020119130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | US20020119129 Introducing expression vector into tissue or organ, vector comprising a recombinant nucleic acid molecule comprising a DNA molecule, or a corresponding RNA molecule, to form a non-translatable double-stranded RNA molecule; grafting |
| 08/29/2002 | US20020119127 Method and system for optimizing minigenes and peptides encoded thereby |
| 08/29/2002 | US20020119121 Compositions and methods for inducing specific cytolytic T cell responses |
| 08/29/2002 | US20020119120 Amino acid substitution mutants of interleukin 13 |
| 08/29/2002 | US20020119118 For diagnosis, therapy of immune related disorders; for identifying a compound that mimics the activity of a Bolekine polypeptide; for stimulating proliferation of T-lymphocytes; enhancing infiltration of inflammatory cells into a tissue |
| 08/29/2002 | US20020119095 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours |
| 08/29/2002 | DE10162386A1 Für das rpsL-Gen kodierende Nukleotidsequenzen For the rpsL gene coding nucleotide sequences |
| 08/29/2002 | DE10108100A1 Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse Use supersekretierbarer peptides in processes for their preparation and parallel improvement of Exportate one or more other polypeptides of interest |
| 08/29/2002 | CA2476397A1 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | CA2451089A1 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 08/29/2002 | CA2445796A1 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | CA2442293A1 Zinc finger binding domains for nucleotide sequence ann |
| 08/29/2002 | CA2441444A1 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 08/29/2002 | CA2440197A1 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/29/2002 | CA2440008A1 Rat toxicologically relevant genes and uses thereof |
| 08/29/2002 | CA2439193A1 Casoase 3 inhibitors |
| 08/29/2002 | CA2438952A1 Lectins for analyzing sugar chains and method of using the same |
| 08/29/2002 | CA2438775A1 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | CA2438769A1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | CA2438628A1 Artificial proteins with reduced immunogenicity |
| 08/29/2002 | CA2438521A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 08/29/2002 | CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | CA2438386A1 Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, hgra4, and splice variant thereof |
| 08/29/2002 | CA2438371A1 Histidine phosphatase interacting protein of 120 kd |
| 08/29/2002 | CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2438148A1 Chemically defined medium for cultured mammalian cells |
| 08/29/2002 | CA2438133A1 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | CA2438119A1 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | CA2438012A1 H. influenzae antigen basb213 |
| 08/29/2002 | CA2437937A1 Method for identifying herbicidally active substances |
| 08/29/2002 | CA2437093A1 Avian mago nashi gene |
| 08/29/2002 | CA2436516A1 Pg-3 and biallelic markers thereof |
| 08/29/2002 | CA2436399A1 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2433841A1 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/28/2002 | EP1235073A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 08/28/2002 | EP1234881A1 Dna fragment having promoter function |
| 08/28/2002 | EP1234880A1 Novel protein tab2 |
| 08/28/2002 | EP1234879A2 Human nucleic acid sequences from prostate tumour tissue |
| 08/28/2002 | EP1234878A1 Use of disease-associated gene |
| 08/28/2002 | EP1234877A1 Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to the polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions for gene therapy by using the same |
| 08/28/2002 | EP1234835A2 Assays for assessing ABeta-Tau Aggregation |
| 08/28/2002 | EP1234586A2 Hepatoselective pharmaceutical actives |
| 08/28/2002 | EP1234583A1 PEG-conjugates of HGF-NK4 |
| 08/28/2002 | EP1234580A1 Acellular Pertussis Vaccines and Methods of Preparation Thereof |
| 08/28/2002 | EP1234579A1 Acellular Pertussis Vaccines and Methods of Preparation Thereof |
| 08/28/2002 | EP1234188A2 Protein kinase regulation |
| 08/28/2002 | EP1234182A2 Hybridization of target dna with immobilized nucleic acid analogs |
| 08/28/2002 | EP1234179A2 Naive screening method |
| 08/28/2002 | EP1234046A2 Udp-glucose:aglycon-glucosyltransferase |
| 08/28/2002 | EP1234044A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/28/2002 | EP1234040A2 Hbv sequences |
| 08/28/2002 | EP1234039A2 85kDa NEISSERIAL ANTIGEN |
| 08/28/2002 | EP1234038A1 Nucleic acid construct for optimized production of products |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234036A2 Compositions and methods for the treatment of immune related diseases |
| 08/28/2002 | EP1234035A1 Human cytokine receptor |
| 08/28/2002 | EP1234034A1 Transfer compounds, the production and the use thereof |
| 08/28/2002 | EP1234033A2 Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 08/28/2002 | EP1234032A1 Novel nucleic acid and polypeptide |
| 08/28/2002 | EP1234031A2 B7-h1, a novel immunoregulatory molecule |
| 08/28/2002 | EP1234030A2 18 human secreted proteins |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234024A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 08/28/2002 | EP1234023A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 08/28/2002 | EP1233986A1 Reduced side-effect hemoglobin compositions |
| 08/28/2002 | EP1233985A1 Collagen |
| 08/28/2002 | EP1233984A2 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233982A2 Novel hcv non-structural polypeptide |
| 08/28/2002 | EP1233981A1 G-protein coupled receptor |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233979A1 Method of diagnosing neurodegenerative disease |
| 08/28/2002 | EP1233978A1 Compositions and methods for the improved diagnosis and treatment of germ cell tumors |
| 08/28/2002 | EP1233977A1 Interleukin-1 homologue, mat il-1h4 |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233974A2 37 staphylococcus aureus genes and polypeptides |
| 08/28/2002 | EP1233785A1 "bonzo" chemokine receptor antibodies and ligands |
| 08/28/2002 | EP1233783A2 Hbv/hcv virus-like particle |
| 08/28/2002 | EP1233782A2 Eliciting hcv-specific antibodies |
| 08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
| 08/28/2002 | EP1233779A2 New uses of suppressive macrophage activation factors |
| 08/28/2002 | EP1233778A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233776A1 Urotensin-ii cyclic analogs |
| 08/28/2002 | EP1233774A1 Urotensin-ii analogs |